Jun 6, 2018
MediSieve at TLA’s HealthTech Innovator Conference
MediSieve has been included in the round-up of the most exciting medical technology companies who presented at the event.
LONDON – June 06, 2018 – Tech London Advocates’ (TLA) HealthTech Working Group and the Health Foundry organised the HealthTech Innovator conference, a London Tech Week event which recently took place.
The event showcased innovative startups and initiatives working in the medical device and pharmaceutical sector that are in the early stages of product development, as well as those seeking investment. MediSieve has been included in the round-up of the most exciting medical technology companies who presented at the event.
About Magnetic Blood Filtration
MediSieve's Magnetic Blood Filtration Platform is intended to enable the rapid and specific depletion of specific agents from the bloodstream of patients. The extracorporeal therapy uses therapeutic Magnetic Beads that are designed to bind specifically to the clinical target. The Beads are introduced into the extracorporeal circuit during the therapy, mixing with the patient’s blood and binding to the clinical targets. The Delivery Platform captures all the Magnetic Beads and bound targets, preventing their return to the patient.
About MediSieve
MediSieve is a London-based BioTech start-up that has developed Magnetic Blood Filtration, a revolutionary platform therapy that enables the physical removal of specific substances from the bloodstream of patients. It can be used (1) as a direct treatment, (2) to increase the safety and efficacy of other therapies, or (3) to enable personalised medicine. The company is a spin-off from University College London and is developing its products at the White City Innovation District in West London. MediSieve is actively seeking investment and partnerships.
MEDIA CONTACT:
Alina Kagermazova
INVESTOR AND PARTNERSHIP CONTACT:
George Frodsham
